Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
Page 2

The organizers of the program reckon that through the leveraging of the strengths, the pace of grant-funded medications development for SUDs will be substantially accelerated. As a result, the organizers encourage the proposals to be submitted under this program to focus at any point along the drug development continuum.

The initiative is also inspired by the fact that there is presently no FDA-approved medications for the treatment of cocaine, methamphetamine, or cannabis use disorders. To this regard, the NIH and NIDA hope that the results of the program will accelerate medication development, foster collaborative ventures between entities such that each offers financial resources, in-kind resources, and/or expertise toward the development of safe and effective medications for SUDs.

To support this program, the NIH and NIDA are willing to administer funds in the amount of $2,000,000 per year for a project that could last for up to 3 years.

The institutions and organizations who will be deemed eligible to take part in the program are the following:

a) Higher Education Institutions such as Public and Private Institutions of Higher Education

b) Nonprofit Organizations

c) For-profit Organizations Such as Small Businesses

d) State Governments, County Governments, City or Township Governments, Special District Governments, and Indian/Native American Tribal Governments

e) Independent School Districts, Public Housing Authorities/Indian Housing Authorities, Native American Tribal Organizations, and Faith-based or Community-based Organizations

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
  Back to Page 1

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on children grants and education grant money.

Additional Resources

category - Health Grants

Leadership Group for a Clinical Research Network on Antibacterial Resistance Program
In line with this mission, the National Institutes of Health has collaborated with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the Leadership Group for a Clinical Research Network on Antibacterial Resistance Program.

---

Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program
In keeping with this mission, the National Institutes of Health has partnered with the Canadian Institutes of Health Research (CIHR), the National Heart, Lung, and Blood Institute (NHLBI), and the Institute of Circulatory and Respiratory Health (ICRH) to establish the Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program.

---

Lifespan Respite Care Program - Technical Assistance Resource Center
In keeping with this mission, the Administration on Aging has recently announced the constitution of the Lifespan Respite Care Program - Technical Assistance Resource Center wherein it aims to invite applications for a competitive grant opportunity for implementing the requirements of the Technical Assistance Resource Center (TARC) as authorized in the Lifespan Respite Care Act of 2006.

---

The Collaborative Islet Transplantation Registry Program
The National Institutes of Health has formed a partnership with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in order to establish the The Collaborative Islet Transplantation Registry Program wherein both agencies seek to invite applications that intend to continue initiatives started through the Collaborative Islet Transplantation Registry (CITR).

---